Diagnostic biomarkers of dilated cardiomyopathy.

Abstract excerpt

BACKGROUND: Dilated cardiomyopathy (DCM) is a condition involving dilation of cardiac chambers, which results in contraction impairment. Besides invasive and non-invasive diagnostic procedures, cardiac biomarkers are of great importance in both diagnosis and prognosis of the disease. These biomarkers are categorized into three groups based on their site; cardiomyocyte biomarkers, microenvironmental biomarkers and...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Biomarkers
• Share to Cardiomyopathy, Dilated
• Share to Cellular Microenvironment
• Share to Disease Management
• Share to Disease Susceptibility
• Share to Heart Function Tests
• Share to Inflammation Mediators
• Share to Myocytes, Cardiac